What Is Sleep Apnea?
Sleep apnea is a disorder in which breathing repeatedly stops and starts during sleep, disrupting oxygen delivery and fragmenting rest. Approximately 18 million American adults have sleep apnea, though many cases remain undiagnosed.1 The condition affects about 13% of men and 6% of women aged 30-70, with prevalence exceeding 40% in individuals with obesity (BMI over 30).2
Obstructive sleep apnea (OSA) accounts for the vast majority of cases. It occurs when throat muscles relax during sleep, physically blocking the airway. Central sleep apnea (CSA) is less common and results from the brain failing to signal breathing muscles properly.3 Both types interrupt sleep architecture and cause daytime symptoms, but OSA involves a mechanical obstruction while CSA reflects neurological dysfunction.
Men face higher risk than women, particularly after age 40. Black, Hispanic, and Asian populations show elevated prevalence compared to non-Hispanic whites, likely due to craniofacial anatomy differences and varying obesity rates.4 Diagnosis rates have climbed over the past two decades as awareness and polysomnography access have improved.
The condition creates a vicious cycle with testosterone. Low testosterone worsens sleep apnea by reducing muscle tone in the upper airway, while sleep apnea itself suppresses testosterone production through repeated oxygen drops during the night. This bidirectional relationship makes addressing both issues critical for men with either condition.
Key Takeaways
Sleep apnea is a disorder where breathing repeatedly stops during sleep, affecting 13% of men and 6% of women aged 30-70. The condition has a bidirectional relationship with testosterone—low testosterone worsens sleep apnea by reducing airway muscle tone, while sleep apnea suppresses testosterone production through repeated oxygen drops. CPAP therapy is the gold standard treatment, often combined with weight loss and lifestyle modifications.
- Obstructive sleep apnea (OSA) accounts for the vast majority of cases and involves physical airway blockage
- Diagnosis requires an AHI of ≥5 with symptoms or ≥15 without symptoms
- Obesity (BMI over 30) is the strongest modifiable risk factor, present in 40%+ of cases
- Weight loss of 5-10% can reduce AHI by approximately 25%
- Men with OSA have 20-30% lower testosterone levels on average
- CPAP therapy aims to reduce AHI below 5 events per hour
Signs and Symptoms
Sleep apnea symptoms vary in presentation and intensity depending on severity.
Loud Snoring
Persistent, disruptive snoring that often prompts bed partner complaints or sleeping in separate rooms.
Gasping for Air
Sudden choking or gasping episodes during sleep, sometimes waking you briefly or noticed by others.
Daytime Fatigue
Persistent exhaustion despite spending adequate time in bed; falling asleep during sedentary activities.
Morning Headaches
Dull frontal headaches upon waking, often resolving within a few hours as oxygen levels normalize.
Symptom severity tracks with how many times breathing stops per hour. Mild OSA (5-14 events hourly) may produce noticeable snoring and occasional daytime sleepiness but often goes unrecognized. Moderate OSA (15-29 events) typically causes clear daytime impairment — struggling to stay alert during meetings, needing afternoon naps, or feeling mentally foggy. Severe OSA (30+ events) creates dramatic functional decline: falling asleep while driving, unrefreshing sleep no matter how long you're in bed, and concentration problems that interfere with work.
Not everyone with sleep apnea snores loudly, and not everyone who snores has apnea. The defining feature is the breathing interruption itself, which fragments sleep architecture and drops blood oxygen levels. Partners may witness these pauses — stretches of silence followed by loud gasps or snorts as breathing resumes. Some men wake frequently without knowing why, attribute the exhaustion to stress or aging, and never connect it to disrupted breathing.
When symptoms first appear, they're easy to dismiss. You might blame work stress for the fatigue or assume snoring is just normal aging. Watch for the combination: loud snoring plus witnessed apneas plus daytime sleepiness that interferes with daily function. That triad warrants evaluation, especially if you also have risk factors like obesity, thick neck circumference (over 17 inches in men), or a family history of sleep apnea.
Obstructive Sleep Apnea (OSA) is a sleep disorder characterized by repeated interruptions in breathing during sleep caused by collapse of the upper airway, resulting in fragmented sleep and reduced blood oxygen levels.
Sleep Architecture refers to the organized pattern of sleep stages and cycles throughout the night, including REM and non-REM phases; disruption of this pattern prevents restorative sleep quality.
Causes and Risk Factors
Sleep apnea results from a combination of anatomical vulnerabilities and physiological factors that narrow or collapse the upper airway.
Airway Collapse & Anatomy
Physical structures narrow the throat: enlarged tonsils or adenoids, a recessed jaw (retrognathia), a large tongue, or excess soft tissue in the pharynx from obesity. During sleep, muscle relaxation allows these tissues to block airflow. Even a small jaw position can reduce airway diameter enough to cause obstruction when lying supine.
Testosterone & Muscle Tone
Low testosterone reduces tone in the genioglossus and other upper airway dilator muscles, making collapse more likely. Men with OSA have 20-30% lower testosterone levels on average, with the lowest readings occurring during apneic episodes when oxygen drops.5 Hypoxia suppresses the hypothalamic-pituitary-gonadal axis, reducing luteinizing hormone pulses and impairing testosterone synthesis.
Obesity & Weight Distribution
A BMI over 30 is the strongest modifiable risk factor for OSA. Visceral adiposity increases neck circumference and reduces lean muscle mass, both of which worsen airway stability. Fat tissue also produces aromatase enzyme, which converts testosterone to estradiol and disrupts hormonal feedback loops. Weight gain of just 10% increases OSA risk fourfold.6
The relationship between sleep apnea and testosterone deficiency runs both directions. OSA causes secondary hypogonadism through repeated oxygen desaturation events that elevate cortisol and suppress nocturnal testosterone production. At the same time, low testosterone worsens OSA by promoting fat accumulation, reducing respiratory muscle function, and increasing sex hormone-binding globulin (SHBG), which lowers free testosterone bioavailability.7 Evidence favors OSA as the initial driver in most cases, but treating either condition can improve the other.
Beyond obesity and hormones, other factors increase risk: alcohol or sedatives before bed (which relax throat muscles further), nasal congestion from allergies or structural issues, smoking (which inflames airways), and sleeping on your back (gravity pulls soft tissue backward). Family history matters — if a parent had OSA, your odds roughly double. Age naturally increases risk as tissues lose elasticity and muscle tone declines.
How Sleep Apnea Is Diagnosed
Diagnosis requires documenting breathing interruptions during sleep and assessing their impact on your health.
Sleep History & Physical Exam
Your doctor asks about snoring, witnessed apneas, daytime sleepiness, and risk factors. They measure neck circumference and check for enlarged tonsils or jaw abnormalities.
Home Sleep Test or Lab Polysomnography
A portable monitor tracks breathing, oxygen levels, and heart rate at home for uncomplicated cases. In-lab polysomnography (PSG) records brain waves, muscle activity, and full cardiopulmonary data for definitive diagnosis.
Apnea-Hypopnea Index (AHI) Scoring
The AHI counts complete breathing stops (apneas) and partial reductions (hypopneas) per hour. AHI of 5-14 is mild, 15-29 moderate, 30+ severe. Diagnosis requires AHI ≥5 with symptoms or ≥15 without.8
Testosterone & Hormonal Labs
Morning total testosterone, free testosterone, LH, FSH, and SHBG assess whether OSA has triggered secondary hypogonadism. Testing before starting TRT is critical to avoid worsening untreated apnea.
The Apnea-Hypopnea Index is the primary diagnostic metric. An apnea means breathing stops for at least 10 seconds; a hypopnea means airflow drops by 30% or more with an oxygen desaturation. Sleep labs count these events overnight and divide by total sleep time. An AHI of 5 to 14 events per hour indicates mild OSA, 15 to 29 is moderate, and 30 or higher is severe. According to the International Classification of Sleep Disorders, you need an AHI of at least 5 with symptoms like excessive daytime sleepiness, or an AHI of 15 or more even without symptoms, to meet diagnostic criteria.8
Screening tools help identify high-risk individuals before formal testing. The STOP-BANG questionnaire scores eight risk factors (snoring, tiredness, observed apnea, blood pressure, BMI, age, neck size, gender); a score of 3 or higher suggests high OSA probability.9 The Epworth Sleepiness Scale quantifies daytime sleepiness with scores over 10 indicating excessive drowsiness.
Testosterone testing matters for men with OSA because the two conditions interact. If your morning total testosterone is below 300 ng/dL on two separate occasions and you have symptoms of hypogonadism, your OSA may have caused secondary testosterone deficiency. Testing LH and FSH helps distinguish primary testicular failure from central suppression. Before considering testosterone replacement therapy, your doctor should confirm OSA is adequately treated — starting TRT with untreated severe apnea can worsen outcomes.
Treatment and Management
Effective sleep apnea management combines mechanical interventions, lifestyle changes, and in some cases hormonal treatment for men with confirmed testosterone deficiency.
CPAP and Devices
Continuous positive airway pressure (CPAP) is the gold standard for moderate to severe OSA. The device delivers pressurized air through a mask, keeping your airway open throughout the night. Proper titration aims to reduce your AHI below 5 events per hour.10 Most men notice clearer thinking and better energy within 1-2 weeks of consistent nightly use.
Oral appliances offer a second-line option for mild to moderate OSA or when CPAP proves intolerable. Custom mandibular advancement devices reposition your lower jaw forward by 50-75% of maximum protrusion, enlarging the airway behind your tongue. They work best when fitted by a dentist experienced in dental sleep medicine and require periodic adjustment to maintain effectiveness.
Lifestyle Changes
Weight loss produces measurable improvement. Losing 5-10% of your body weight can reduce AHI by roughly 25%, and some men achieve complete resolution with sustained weight reduction. The mechanism is straightforward: less fat around the neck and abdomen means less mechanical compression of the airway.
Sleep position matters. Many men have positional OSA — apneas occur primarily when sleeping on the back. Using a tennis ball sewn into the back of a shirt or specialized positional alarms can train you to stay on your side. Avoiding alcohol and sedatives for 3-4 hours before bed prevents additional muscle relaxation that worsens collapse.
Treating nasal obstruction improves CPAP tolerance and may reduce OSA severity. Septoplasty for a deviated septum or turbinate reduction can open nasal passages. In select cases with significant anatomical abnormalities — extremely enlarged tonsils, severe retrognathia — surgical options like uvulopalatopharyngoplasty or jaw advancement may be considered, though success rates vary.
Testosterone Replacement Therapy
The relationship between TRT and sleep apnea is complex. Some evidence shows testosterone can improve OSA in hypogonadal men by increasing upper airway muscle tone and reducing visceral fat. A 2013 randomized trial of 20 men with low testosterone and OSA found that 10 grams of daily testosterone gel reduced AHI by 3.8 events per hour after 17 weeks, with improved daytime sleepiness.11 A meta-analysis showed men with low testosterone have roughly twice the odds of OSA compared to those with normal levels.12
But other studies show TRT can worsen apnea, particularly in men with untreated moderate to severe OSA. A 2019 trial found TRT increased AHI by 15% in eugonadal men, likely by increasing neck circumference and soft tissue mass.13 The Endocrine Society recommends screening for OSA before starting TRT and ensuring adequate apnea management is in place.14
If you have documented secondary hypogonadism from OSA (morning total testosterone below 300 ng/dL on two occasions, low LH and FSH), TRT may offer benefit — but only as an adjunct to CPAP or another primary OSA treatment, not as monotherapy. Your doctor should recheck PSG after 3 months of CPAP to confirm adequate control before considering testosterone. If you start TRT, hormone labs every 6-12 months and continued CPAP compliance monitoring are essential.
Monitoring and Follow-Up
After starting CPAP, follow-up PSG at 3 months confirms your AHI is controlled and pressure settings are optimal. Device downloads track compliance — you need at least 4 hours of use per night on 70% of nights to see meaningful benefit. If daytime symptoms persist despite good CPAP adherence, your doctor may adjust pressure or investigate other causes like narcolepsy or depression.
For men on TRT, monitoring includes morning testosterone levels every 3-6 months initially, then annually once stable, plus PSA checks for prostate safety in men over 40. If OSA symptoms worsen after starting TRT — increased snoring, return of daytime sleepiness — a repeat sleep study may be needed to adjust CPAP settings or reconsider dosing.
Weight loss effects accumulate over weeks to months. Track your BMI and neck circumference quarterly. Some men improve enough with weight loss and lifestyle changes to reduce CPAP pressure or even discontinue it, but this requires formal retesting to confirm rather than assuming improvement.